GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (BOM:524396) » Definitions » Other Income (Expense)

Biofil Chemicals & Pharmaceuticals (BOM:524396) Other Income (Expense) : ₹1.2 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Other Income (Expense)?

Biofil Chemicals & Pharmaceuticals's other income expense for the Biofil Chemicals & Pharmaceuticals's pretax income for the three months ended in Dec. 2023 was ₹0.3 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.2 Mil.

Biofil Chemicals & Pharmaceuticals Other Income (Expense) Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Other Income (Expense) Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 1.50 7.79 1.50 0.97

Biofil Chemicals & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.33 0.25 0.32 0.28

Biofil Chemicals & Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals  (BOM:524396) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (BOM:524396) » Definitions » Other Income (Expense)
Comparable Companies
BOM:524202 BOM:542934 BOM:524652 BOM:530233 BOM:524711 BOM:524636 BOM:506919 BOM:530317 BOM:539938 BOM:542248 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
BIOFILCHEM:India
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Website
https://www.biofilgroup.net
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Headlines

No Headlines